Principal Scientist, Translational Biology, LNP Discovery

Merck•Billerica, MA
•$126,900 - $215,400

About The Position

The Principal Scientist, Translational Biology, LNP Discovery is a scientific and cross-functional role in the Research Unit Neuroscience & Immunology (N&I). The position defines and executes in vivo translational biology strategies for LNP delivery programs, with particular emphasis on designing, managing, and interpreting non-human primate (NHP) studies to characterize differentiated, targeted LNP candidates. The scientist works closely with formulation/CMC, protein engineering, analytical, toxicology, and translational teams. The role owns in vivo strategy for LNP discovery disease biology programs, including target-cell-directed delivery, pharmacology, dose selection, tolerability and safety, candidate nomination, and IND-enabling planning. It provides scientific oversight of NHP studies from design through execution, including CRO and partner-site delivery, data quality, animal-welfare and ethics requirements, and interpretation of integrated safety, exposure, biodistribution, and pharmacology results. The position also supports candidate comparisons and selection, communicates recommendations to stakeholders, and authors and reviews study protocols and reports. The role does not offer work-authorization sponsorship. External applicants must be eligible to work in the United States. The stated base pay range is $126,900–$215,400; actual compensation depends on factors including location, experience, education, and skills. The position may be eligible for sales or performance-based bonuses. Company benefits include health insurance, paid time off, retirement contributions, and other perquisites.

Requirements

  • PhD or similar degree in pharmacology, toxicology, immunology, cell biology, molecular biology, or a related discipline.
  • At least 8 years of post-PhD experience in biotech, pharma, or an equivalent translational academic setting.
  • At least 4 years independently leading in vivo programs and NHP studies.
  • Clear written and verbal communication skills, including the ability to present study plans, data, risks, and recommendations to leadership, partners, and advisors.

Nice To Haves

  • Demonstrated expertise planning, managing, and interpreting NHP studies, including CRO oversight, protocol development, dose and regimen selection, sampling strategies, study-quality review, and data review.
  • Strong experience evaluating nonclinical safety and tolerability and integrating clinical observations, clinical pathology, cytokine and complement responses, immunogenicity, exposure, and tissue findings; ability to distinguish modality-related signals from study or assay artifacts.
  • Experience supporting candidate selection and/or IND-enabling development; familiarity with GLP study conduct and nonclinical regulatory expectations.
  • Direct experience with GLP NHP studies.
  • Working knowledge of LNP biology and delivery, including biodistribution, PK/PD, and immune responses; experience with LNPs or other nucleic-acid delivery platforms.
  • Practical understanding of bioanalytical methods used in in vivo studies, such as flow cytometry and molecular or ligand-binding assays, and of fit-for-purpose assay performance and limitations.
  • Evidence of scientific leadership through first- or senior-author publications, patents, or programs with clear personal ownership.
  • Demonstrated success influencing cross-functional or global project teams without formal authority.

Responsibilities

  • Define and own in vivo strategies for LNP discovery disease biology programs, covering target-cell-directed delivery, pharmacology, dose selection, tolerability and safety, candidate nomination, and IND-enabling planning.
  • Design NHP studies and provide scientific oversight throughout execution, including rationale for models and species, objectives, group structure, dose levels, route and schedule, recovery periods, sample-collection cadence, and fit-for-purpose endpoints.
  • Oversee CRO and partner-site delivery of NHP studies by scoping and reviewing protocols, aligning operational plans and data standards, monitoring timelines and data quality, resolving deviations, and addressing animal-welfare and IACUC/ethics requirements.
  • Define and interpret integrated pharmacology and safety assessments, including clinical observations, body weight, clinical pathology, cytokines, complement activation, immunogenicity, PK/exposure, biodistribution, and tissue pathology as appropriate.
  • Integrate safety, exposure, biodistribution, and pharmacology data to identify LNP-related risks, assess dose margins, recommend mitigation strategies, and support evidence-based go/no-go and candidate-selection decisions.
  • Partner with formulation, lipid chemistry, targeting-ligand, and protein-engineering teams to translate in vitro potency, selectivity, and developability data into NHP study designs that discriminate among candidates.
  • Review head-to-head comparisons against internal, commercial, and published benchmarks, explaining differences in study design and readouts.
  • Author and review study protocols and reports; present data and recommendations to leadership, partners, and advisors as programs mature.

Benefits

  • Health insurance
  • Paid time off (PTO)
  • Retirement contributions
  • Other perquisites
  • Position may be eligible for sales or performance-based bonuses.

Stand Out From the Crowd

Upload your resume and get instant feedback on how well it matches this job.

Upload and Match Resume

What This Job Offers

Job Type

Full-time

Career Level

Principal

Education Level

Ph.D. or professional degree

© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service